Skip to main content
. 2023 Aug 3;12(8):1278. doi: 10.3390/antibiotics12081278

Table 3.

Distribution between non-ROs and ROs during the observation time.

Non-ROs (%) ROs (%) Patients (N)
2018 142 (80.23) 35 (19.77) 375
2019 199 (86.90) 30 (13.10) 371
2020 179 (74.27) 62 (25.73) 337
2021 174 (79.45) 45 (20.55) 309
2022 165 (77.10) 49 (22.90) 287